Tni Medical AG

Tni Medical AG specializes in two primary categories of respiratory devices: single-use inspiratory line humidification chambers and professional high-flow respiratory units with manual humidification. These devices are designed to deliver humidified gas therapy, ensuring precise moisture control during inhalation for clinical and homecare settings. The company’s focus is on products that enhance respiratory care by maintaining optimal humidity levels.

Tni Medical AG is based in the United States. Since its devices are manufactured and regulated under US medical device laws, they fall under the jurisdiction of the FDA. The company’s products are classified as Class II devices, which means they undergo specific regulatory pathways, including pre-market notifications (510(k)) and unique device identification (UDI) requirements, to ensure safety and performance before reaching the market.

Tni Medical AG’s devices are listed in the FDA’s 510(k) and UDI registries. The 510(k) pathway is used for pre-market submissions to demonstrate that a device is substantially equivalent to a legally marketed predicate device, while the UDI system ensures accurate identification and traceability of medical devices throughout their lifecycle. These registries help track compliance and transparency in the regulatory process.

Tni Medical AG’s devices are classified as Class II under US medical device regulations. This classification applies to devices that generally pose moderate risk and require special controls beyond general controls to ensure their safety and effectiveness. Class II devices typically require pre-market notifications (510(k)) to demonstrate equivalence to existing approved devices, ensuring they meet regulatory standards before commercial distribution.